Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-011525

CHIEF MEDICAL OFFICER sold 29,000 shares at an average $19.14 ($555,160)

  • CHIEF MEDICAL OFFICER acquired 29,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Paolini John F. CHIEF MEDICAL OFFICER 2023-07-25 Option exercise +29,000 $1.86 $53,940 70,910 D
Paolini John F. CHIEF MEDICAL OFFICER 2023-07-25 Sale −5,200 $18.01 $93,652 65,710 D
Paolini John F. CHIEF MEDICAL OFFICER 2023-07-25 Sale −16,168 $19.25 $311,234 49,542 D
Paolini John F. CHIEF MEDICAL OFFICER 2023-07-25 Sale −7,632 $19.69 $150,274 41,910 D
Derivatives
Paolini John F. CHIEF MEDICAL OFFICER 2023-07-25 Option exercise · Share Option −29,000 140,217 D
Open-market sales · 29,000 sh · avg $19.14 · $555,160
Loading xslF345X05/form4-07272023_080730.xml…